Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 701,780 | 659,191 | 616,981 | 620,040 | 599,046 |
| Cost of Goods | 451,833 | 421,131 | 427,154 | 387,509 | 379,025 |
| Gross Profit | 249,947 | 238,060 | 189,827 | 232,531 | 220,021 |
| Operating Expenses | 155,310 | 248,937 | 175,788 | 157,392 | 139,962 |
| Operating Income | 95,470 | -10,746 | 14,193 | 75,648 | 80,084 |
| Interest Expense | 65,719 | 65,703 | 59,548 | 50,909 | 50,857 |
| Other Income | -9,346 | 927 | -38,106 | -1,782 | 433 |
| Pre-tax Income | 20,405 | -75,522 | -83,461 | 22,957 | 29,660 |
| Income Tax | 3,618 | 6,156 | 9,883 | -2,076 | -23 |
| Net Income Continuous | 16,787 | -81,678 | -93,344 | 25,033 | 29,683 |
| Minority Interests | 10,793 | 9,965 | 5,305 | 15,351 | 17,766 |
| Net Income | $5,994 | $-91,643 | $-98,649 | $9,682 | $11,917 |
| EPS Basic Total Ops | 0.02 | -0.30 | -0.57 | 0.06 | 0.08 |
| EPS Basic Continuous Ops | 0.05 | -0.27 | -0.57 | 0.16 | 0.19 |
| EPS Diluted Total Ops | 0.02 | -0.30 | -0.57 | 0.06 | 0.08 |
| EPS Diluted Continuous Ops | 0.05 | -0.27 | -0.56 | 0.16 | 0.19 |
| EPS Diluted Before Non-Recurring Items | 0.15 | 0.12 | 0.12 | 0.17 | 0.16 |
| EBITDA(a) | $151,975 | $45,070 | $72,424 | $135,215 | $139,660 |